OKUR Stock Summary and Trading Ideas (Onkure Therapeutics - Class A | NASDAQ:OKUR)

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Ka. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.

As of April 28, 2026, OKUR stock price climbed to $5.22 with 127,495 million shares trading.

OKUR has a beta of 0.68, meaning it tends to be less sensitive to market movements. OKUR has a correlation of 0.02 to the broad based SPY ETF.

OKUR has a market cap of $214.45 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, VXF, IWC, DFAS, AVSC.

OKUR has outperformed the market in the last year with a price return of +105.5% while the SPY ETF gained +30.5%. OKUR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +84.5% and +13.4%, respectively, while the SPY returned +2.6% and +2.5%, respectively.

OKUR support price is $4.74 and resistance is $5.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.